ABSTRACT. Calcium transporter genes, such as transient receptor potential cation channel subfamily V members 5/6 (TRPV5/6), Na + /Ca 2+ exchanger 1 (NCX1), and plasma membrane calcium-transporting ATPase 1b (PMCA1b), are essential for maintaining homeostasis and metabolizing Ca 2+ ions. The TRPV5 and TRPV6 proteins play an important role in Ca 2+ absorption, and NCX1 and PMCA1b are both critical for intracellular calcium homeostasis. In this study, the tissue-specific mRNA and protein expression of these calcium transporter genes in the duodenum, kidney and heart of the horse (Equus caballus) was examined using reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blot analysis. The tissue localization of these calcium transporters was also investigated using immunohistochemistry. The results showed that TRPV5 mRNA was highly expressed in the kidney but was scarce in the duodenum and heart. TRPV6 mRNA levels were similar in all the tissues. NCX1 and PMCA1b were both highly expressed in the heart, but no difference in NCX1 and PMCA1b mRNA expressions was observed in the duodenum and kidney. The aspect of protein expression was similar with mRNA expression data. Localization of calcium transporter genes were detected enterocytes in duodenum, the distal convoluted tubules in the kidney, and within the cardiac muscle cells of the heart. Based on these results, calcium transport genes appear to be expressed in horse tissues at levels similar to those observed in other vertebrates.
Calcium is important for the overall maintenance of living organisms and is critical for strengthening bones, neurotransmitter release, and muscle contractions. It also functions as a second messenger, activates intracellular signaling, contraction and blood clotting and so on. Calcium deficiency results in symptoms such as muscle pain, muscle spasms, indigestion, diarrhea, an irregular menstrual cycle, pale skin, and listlessness. Deficiency can also result in osteoporosis, osteomalacia, rickets, and anemia [36] . Problems can also stem from absorbing too much calcium, including the formation of kidney stones, constipation and loss of appetite, nausea, seizures and even coma. Excess calcium retention can also lead to decreased absorption of other minerals [1] . Therefore, maintaining an appropriate calcium concentration is essential.
The regulation of calcium concentration is controlled by three factors: parathyroid hormone (PTH), vitamin D, and calcitonin. The main role of PTH is to elevate blood calcium levels when required. PTH release causes the gastrointestinal tract to absorb more calcium, and it also triggers the release of calcium stored in bones and stimulates the kidney to excrete more phosphorous [41] . Vitamin D works in concert with PTH in bone and the kidneys and is necessary for intestinal calcium absorption [24] . The role of calcitonin is opposite to that of PTH, i.e., it decreases the calcium concentration in the blood by reducing osteoclast activity in bone and stimulates phosphate resorption in the kidney tubules [8] .
In transcellular pathway, the dietary calcium is absorbed majorly in the duodenum [27] , and the excreting calcium is reabsorbed in the kidney [17] . The (re)absorbed calcium amount is regulated by the homeostasis of calcium level in body. Therefore, duodenum and kidney are the main tissues in which these regulatory reactions, which result in the maintenance of an adequate extracellular calcium concentration. In cardiac muscle, calcium is used for electrical conduction. Calcium potentiates the action potential and creates a plateau phase resulting in a dynamic equilibrium [26] . By definition, calcium transporters transport calcium ions from the cytosol to the blood-stream. They are classified as calcium channel proteins (which reside in the cell membrane and allow calcium entry into cells), cytosolic buffering or transferring proteins, and excretory pump proteins [9, 30] .
Transient receptor potential vanilloid (TRPV) is a family of transient receptor potential (TRP) ion channels that are selective for calcium and magnesium ions rather than sodium ions [10, 50] . In vertebrates, there are six TRPV channels that fall into 2 groups: group 1 comprises TRPV1-4 and group 2 comprises TRPV5 and TRPV6 (originally called ECaC and CaT, respectively). TRPV5 and TRPV6 are highly calcium-sensitive cation channels and are responsible for limiting the rate of calcium entry into cells during trans-cellular calcium (re)absorption [22, 34, 39] . TRPV5 supports the active resorption of calcium in the distal convoluted tubule of the kidney by facilitating apical calcium entry [21] and is essential for bone resorption by osteoclasts [49] . TRPV5 deficiency is associated with polyuria, urine acidification, and reduced bone thickness [33] . TRPV6 plays a role in calcium absorption in the apical brush-border membrane of the intestine [39] and is also associated with keratinocyte differentiation, fetal bone mineralization, and prostate and breast cancer [5, 31, 45, 51] . TRPV6 expression in the small intestine is regulated by vitamin D, which supports TRPV6 in the absorption of dietary calcium [47, 54] . TRPV6 is abundant in the duodenum and jejunum, as are calcium binding proteins and calcium pumping ATPases. TRPV5 and TRPV6 are responsible for the ratelimiting step that governs calcium influx during active (re)absorption in the kidney, proximal small intestine and placenta [21, 23] . For the (re)uptake of calcium ion in duodenum or kidney, there are two major pathways; transcellular, paracellular [27] . In transcellular pathway, the calcium transporter genes are essential for calcium (re)uptake, and regulation. TRPV5/6 are channel proteins which take calcium ion from luminal space to epithelial cell. PMCA1b and NCX1 play a role in excretion of cellular calcium at the basolateral membrane [48] . Because of their role, they are called as calcium transporter genes.
Sodium-calcium exchanger 1 (NCX1) is a counter-transporter membrane protein found in the plasma membrane, mitochondria, and endoplasmic reticulum of excitable cells [28, 38] , where it functions to excrete intracellular calcium. NCX1 is also involved in controlling neurosecretion, cardiac muscle relaxation, excitation-contraction coupling, and maintaining low calcium concentrations in the mitochondria [13] . The calcium exporting function of NCX1 is reversible, which means that NCX1 is a bidirectional transporter. When intracellular calcium concentrations increase, NCX1 discharges calcium and vice versa [3, 52, 53] . NCX1 is affected by both sodium and calcium ions [2, 19, 20, 32] , protons [14, 15] , and phosphatidylinositol 4,5-biphosphate in the cell membrane [18] . NCX1 uses energy stored in the electrochemical gradient created by sodium ions flowing across the membrane. For every three sodium ions entering the cell, one calcium ion is discharged into the extracellular space by NCX1 [53] .
Plasma membrane calcium-transporting ATPase (PMCA) is a transport protein found in the plasma membrane of cells. It transports calcium from inside the cell to the extracellular space using energy derived from ATP hydrolysis. This action is essential for the vitality of the cell [25] . In the brain, PMCA is important for regulating synaptic activity. PMCA1 is one of four PMCA isoforms. In humans, the enzyme is encoded by the ATP2B1 gene [37] . PMCA1 comprises two subtypes: PMCA1a and PMCA1b. PMCA1b is ubiquitous in all tissues and is essential for the survival of the embryo. Defects in the PMCA protein can result in deafness, diabetes and hypertension [46] .
Balancing calcium concentration is also important in horses. As in humans, the regulation of calcium concentration in horses depends on the expression of calcium transporter genes; however, to date, only mRNA expression for these calcium transport genes has been described [42] . In the present study, the expression levels of TRPV5/6, NCX1, and PMCA1b mRNA and protein in horses was examined using RT-PCR and Western blot analysis. The tissue localization of these transporter proteins was also investigated using immunohistochemistry.
MATERIALS AND METHODS
Animals: Duodenum, kidneys and heart were collected from 20 year-old thoroughbred male horses (Equus caballus). The horses were euthanized using a captive barbiturate overdose and arterial hemorrhage. All samples were provided by the Korean Equestrian Federation.
RNA extraction and semiquantitative RT-PCR: Total RNA was extracted using the Trizol reagent (Invitrogen Co., Carlsbad, CA, U.S.A.) according to the manufacturer's instructions and the concentration of total RNA was determined by measuring the absorbance at 260 nm. Total RNA was denatured by heating to 85°C for 10 min and 10 g was then electrophoresed on 1% formaldehyde denaturing agarose gels for 1 hr at 110 volts using 18s rRNA to indicate the quantity of total RNA. First strand complementary DNA (cDNA) was prepared by subjecting total RNA (1 g) to reverse transcription using mMLV reverse transcriptase (Invitrogen CO.,) and random primers (9-mers; TaKaRa Bio Inc., Otsu, Shiga, Japan). To determine the conditions for logarithmic phase PCR amplification of the target mRNA, aliquots (1 g) were amplified using different numbers of cycles. A linear relationship between PCR product band visibility and the number of amplification cycles was observed for the target mRNAs. cDNA was amplified in a 20 l PCR reaction containing 1 U Taq polymerase (iNtRON Bio Inc., Sungnam, Kyngki-Do, Korea), 2 mM dNTPs, and 10 pmol specific primers. The PCR conditions were: denaturation at 95°C for 30 sec, annealing at 58°C for 30 sec, and extension at 72°C for 30 sec. The primers used were: TRPV5, 5'-TGATG GGTGA CACAC ACTGG-3' (sense) and 5'-GAAGC ACTCG CAAAG GATTT-3' (antisense); TRPV6, 5'-GGTTC ACTTG CTTCT TTGGA-3' (sense) and 5'-CAGTA CCAGG GCAAA GGACA-3' (antisense); NCX1, 5'-GGTTG GGACA AACAG CTGGA-3' (sense) and 5'-AATCT TTCAG GCCAA TGGTG-3' (antisense); and PMCA1b, 5'-ATCTC TCGGA CCATG ATGAA-3' (sense) and 5'-GCTGC ATCAT GACGA AGGTG-3'(antisense). PCR products (8 l) were separated on 2.3% agarose gels, stained with ethidium bromide and photographed under UV illumination. The photograph was then scanned using a Gel Doc EQ system (Biorad Laboratories, Inc., CA, U.S.A.).
Western blot analysis: Positive controls (murine heart and kidney and human uterus) were rapidly excised, washed in cold sterile 0.9% NaCl solution, and protein extracted using Pro-prep (iNtRON Bio Inc.) according to the manufacturer's instructions. Cytosolic proteins (50 μg per lane) were run on 10% SDS-PAGE gels and transferred to polyvinylidene fluoride transfer membranes (Perkin Elmer Co., Wellesley, MA, U.S.A.) in a TransBlot Cell (TE-22, Hoefer Co., Ca., U.S.A.). The resulting blot was blocked with TBS-T containing 5% skim milk for 2 hr and incubated with rabbit anti-TRPV5 (1:500, Santa Cruz, CA, U.S.A.), goat anti-TRPV6 (1:500 , Santa Cruz), goat anti-NCX1 (diluted 1:500, Santa Cruz), rabbit anti-PMCA1b (1:500, Swant, Bellinzona, Switzerland), or mouse anti--actin (1:1,000, Millipore, Bedford, MA, U.S.A.). After washing in buffer, the membranes were incubated with the appropriate horseradish peroxidase-conjugated secondary antibodies (1:2,500, Santa Cruz) for 2 hr at room temperature. After washing, the blots were developed using the enhanced chemiluminescence reagent (Amersham Biosciences, Little Chalfont, UK) and exposed to Biomax™ Light film (Kodak) for 1 to 5 min. Signal specificity was ensured by omitting each primary antibody and bands were normalized to -actin.
Immunohistochemistry: The tissue localization of the calcium transporter genes was examined using immunohistochemistry. Samples of duodenum, kidney and heart were embedded in paraffin, cut into 5 m sections, mounted on glass slides, deparaffinized using xylene and hydrated in descending graded ethanol solutions. Endogenous peroxidase activity was blocked with 3% hydrogen peroxide in TBS-T for 30 min. Nonspecific reactions were blocked by incubating the sections in 10% normal goat serum. After washing with TBS-T, the sections were incubated with biotinylated secondary antibodies (goat IgG for TRPV6 and NCX1, and rabbit IgG for TRPV5 and PMCA1b; Vector laboratories, Burlingame, CA, U.S.A.) for 30 min at 37°C followed by incubation with ABC-Elite (Vector Laboratories, Inc.) for 30 min at 37°C. Diaminobenzidine (Sigma, St Louis, MO, U.S.A.) was used as the chromogen and the sections were counterstained with hematoxylin prior to mounting in Canada balsam.
RESULTS

Tissue-specific expression of calcium transporter genes:
The tissue-specific expression of TRPV5/6, NCX1, and PMCA1b was analyzed by RT-PCR and Western blot analysis. TRPV5 mRNA was highly expressed in the kidney but scarcely expressed in the duodenum and heart (Fig. 1) . However, the TRPV5 protein was detected at similar levels in all the tissues tested (Fig. 2) . TRPV6 mRNA and protein were expressed in the duodenum, kidney and heart (Figs. 1 and 2). NCX1 mRNA was moderately expressed in the duodenum, kidney and heart, although the level in the heart was somewhat higher than that in the other tissues (Fig. 1) . NCX1 protein was expressed in the duodenum, kidney and heart of horse, but there is no significant difference (Fig. 2) . PMCA1b mRNA was expressed in the duodenum, kidney and heart, but its expression level was markedly higher in the heart than in the other tissues (Fig. 1) . The pattern of PMCA1b protein expression was similar to that of the mRNA (Fig. 2) .
Localization of calcium transporter genes in the duodenum, kidney and heart: The localization of the calcium transporter genes was examined using immunohistochemistry. The calcium transporter proteins were detected at similar levels in the horse duodenum, kidney and heart, and were localized to enterocytes in duodenum, the distal convoluted tubules in the kidney, and within the cardiac muscle cells of the heart. TRPV5 was observed in the kidney, but not clear in the duodenum and heart, although the staining was slightly low in general (Fig. 3A) . TRPV6 was stained strongly in all tissues (Fig. 3B) . NCX1 expression was observed in all tissues, but PMCA1b was more highly expressed in the duodenum than in the kidney and heart (Fig. 3D ).
DISCUSSION
Calcium performs many functions essential for life; therefore, it is essential to maintain appropriate calcium levels for health. Calcium homeostasis is maintained by calcium transporter proteins. There are many studies reporting the expression of calcium transporter genes and proteins in rats, mice and humans; however, only mRNA expression has been reported in horses [42] . This raised the question of how calcium transporter genes are expressed and localized in horses. In this study, the expression and tissue localization of four calcium transporter genes (TRPV5/6, NCX1, and PMCA1b) was investigated. The tissues chosen were the duodenum, kidney and heart because the duodenum and kidney are the main organs involved in calcium regulation and the heart is an organ in which calcium is involved in the electrical conduction systems. mRNA and protein expression was assessed by RT-PCR and Western blotting, respectively, and tissue localization was visualized using immunohistochemistry.
The results showed that, in horses, the expression and localization of TRPV5 was different from that observed in other animals. For example, some reports suggest that TRPV5 is predominantly expressed in the kidney in other animals [11, 29] and in horses [42] . In agreement with these studies, our results showed that TRPV5 mRNA expression level was highest in kidney. However, the expression pattern of the TRPV5 protein was different. This may be due to the specificity of the primary antibody used in the Western blotting experiments in the present study. In this study, an anti-TRPV5 antibody specific to a mouse and rat TRPV5 was used, indicating that that this antibody may cross-react with a horse TRPV5. Since there is homology between horse and rodent sequences of TRPV5, it can be assumed that TRPV5 protein was expressed in the tissue of horse.
The expression levels of TRPV6 mRNA and protein appeared similar, although there were some insignificant differences between the tissues. TRPV6 was localized in the duodenum, kidney and heart. TRPV6 is involved in calcium (re)absorption and muscle contraction. Both TRPV5 and TRPV6 are responsible for apical calcium entry during absorption, but the main role of TRPV5 is in the kidney and that of TRPV6 is in the duodenum. However, there are some reports of co-expression in these tissues [35] . TRPV5 and 6 may even form heterotetramers to facilitate active calcium resorption in the kidney [35] . We suggest that this may also be the case in horse tissues. Taken together, our data indicate that, in horses, TRPV5 and TRPV6 are also essential for facilitating active (re)absorption in the duodenum and kidney and for supporting the conduction system of the heart.
NCX1 mRNA was abundantly expressed in the heart, but the pattern of NCX1 protein expression was different. NCX1 was localized in the duodenum, kidney and heart tissues, but as was the case for TRPV5, we did not have access to a horse-specific NCX1 antibody for use in immunohistochemistry. NCX1 is ubiquitously expressed in mammalian heart and brain tissue, where it is responsible for calcium homeostasis [43] , although it is also widely expressed in other tissues [4, 40] . NCX1 participates in essential processes such as balancing calcium ion concentrations by regulating duodenal mucosal ion transport and HCO3-secretion and controlling calcium ion homeostasis [16] . NCX1 also participates in cardiac muscle relaxation and in the maintenance of calcium concentration in the sarcoplasmic reticulum in cardiac cells [13] .
Analysis of PMCA1b mRNA and protein expression levels showed that expression was significantly higher in the heart, although PMCA1b expression was localized in all the tissues tested. However, the Western blotting data revealed some differences. The PMCA1b protein in heart appeared to be about 160 kDa, whereas it was about 140 kDa in the duodenum and kidney. A study using the same anti-PMCA1 antibody used in the current study noted that PMCA1b was detected in placenta as bands of 140 kDa and 160 kDa [12] . Because the tissues and animals used in our study are different, it cannot be said for certain that the particular antibody used was the reason for the different PMCA1b bands seen in heart tissue, but it is certainly a possibility. PMCA1b is the ubiquitously expressed isoform of PMCA in mammalian tissues, where it functions as a transport protein responsible for regulating calcium balance by moving intracellular calcium out into the extracellular space [44] . Opposite to NCX1, PMCA1b has a high affinity and a low capacity for calcium. The maintenance of low calcium concentrations is very important for efficient cell signaling [6] . NCX1 has a low affinity for calcium but has a high capacity, so it is useful for removing large concentrations of calcium (it is capable of transporting about five thousand calcium molecules per second) [7] . PMCA1b has low capacity but high affinity; therefore, it is useful for maintaining low cellular calcium levels. Thus, the actions of NCX1 and PMCA1b are complementary. NCX1 and PMCA1b are the main regulators of intracellular calcium concentration by acting against the large transmembrane electrochemical gradient that drives ions into the cell. Our results suggest that NCX1 and PMCA1b perform essential calcium balancing roles in horses as well as other mammals.
In summary, the results of this study confirm the expression and localization of calcium transporter genes in horses. Although there were some differences in expression levels, all the calcium transporter genes studies were expressed in duodenum, kidney and heart tissue. Specific locations included the enterocytes of the duodenum, the distal convoluted tubules of the kidney, and the cardiac muscle cells of the heart. These results indicate that TRPV5/6 appear to facilitate apical calcium entry during (re)absorption, and that NCX1 and PMCA1b maintain the calcium balance by transporting calcium ions out of cells. The results of this study also suggest that the expression and localization of these calcium transporter genes in horses is similar to that observed in other vertebrates.
